Tricuspid atresia laboratory findings: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Template: Tricuspid atresia}} | {{Template: Tricuspid atresia}} | ||
__NOTOC__ | |||
{{Template:Tricuspid atresia}} | |||
{{CMG}} '''Associate Editor-In-Chief:'''{{Sara.Zand}} | |||
Laboratory Findings | Laboratory Findings | ||
Revision as of 16:53, 24 August 2020
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia laboratory findings |
|
Risk calculators and risk factors for Tricuspid atresia laboratory findings |
|
Tricuspid atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Tricuspid atresia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Tricuspid atresia laboratory findings |
|
Risk calculators and risk factors for Tricuspid atresia laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief:Sara Zand, M.D.[2] Laboratory Findings
In cyanotic older patients laboratory finding may include:
- Polycythemia due to secondary erythrocytosis
- Elevated prothrombin time and partial thromboplastin time
- Decreased levels of factors 5,7,8,9: qualitative and quantitative
- Platelet disorder
- Increased fibrinolysis and paradoxical thrombotic tendency
- Proteinuria
- Hyperuricemia
- Renal failure
- Uric acid nephrolithiasis